STENTiT Nominated for the Most Pioneering Innovations in Science

STENTiT has been nominated for the Academic Startup Competition 2019. Together with 26 other nominees, STENTiT is fighting for a place in the top ten of the most pioneering innovations of science in the Netherlands.

The Academic Startup Competition is an initiative of VSNU, the Dutch Academy of Technology and Innovation (AcTI) and StartupDelta. The election consists of a nomination by the various universities in the Netherlands and a final on May 14th, where a jury ultimately selects ten winners as part of the list of the most pioneering innovations in science in the Netherlands. During the Global Entrepreneurship Summit (GES) on 4 and 5 June in The Hague, these startups will have the opportunity to present their company to a global audience.

TU Eindhoven has nominated STENTiT, a company which developed a technology to create regenerative stents. By using a new production method, fibrous porous structures can be implanted minimally-invasively into diseased arteries to provide instant structural support, where after the circulating blood cells are triggered to initiate a natural healing response to restore the artery.

Election
With the election, the organizers put international valorization and academic spin-offs in an international spotlight. Jorrit Kuipers, member of the AcTI board: “Academic startups are extremely important for the Netherlands because of their often innovative breakthroughs that impact society in many ways. But knowledge alone is not enough, you also need entrepreneurship and the drive this knowledge to market. The selected startups are all good examples of how science and entrepreneurship can strengthen each other and the proof that the Dutch Univeristies produce wonderful (deep-)tech companies. ”

Competition
The ten winners presenting on June 4th and 5th for the Global Entrepeneurship Summit (GES), will be selected in the Amsterdam epicenter on May 14th by Betsy Lindsey, director of investor relations HighTechXL, Kees de Koning, RvC Innovationquarter, Dennis Schipper, general director Demcon , Margot Weijnen, TU Delft professor, Emile Aarts, Jos Nelissen, founder Newtricious, Eline Vrijland, founder Nightbalance, Alberto Prado, Philip Healthworks and Fiona Maclaughlin, director Inkef Capital

The nominated companies are: Sensius, Numeric Biotech, 20face, hy2Care, Kepler Vision Technologies, Cardiac Booster, Bunyavax, MindAffect, Amphera, US Particle, Concord Neonatal, LipoCoat, Level Diagnostics, Chromodynamics, CC Diagnostics, IVWear, Ocean Grazer, Confocal, Elevate Health, Dialogue Trainer, Mosa Meat, i-Med Technology, Arthrosave, Taylor, Scitodate, STENTiT and Findest.

Check the website for more information about the competition, jury and the various startups